

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.97010033 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.79141728 |
| 3 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.77171591 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 4.62035155 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 4.62035155 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.62035155 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.62035155 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.62035155 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 4.62035155 |
| 10 | immunoglobulin mediated immune response (GO:0016064) | 4.50411834 |
| 11 | positive regulation of B cell differentiation (GO:0045579) | 4.32592189 |
| 12 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.22313148 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 4.16045972 |
| 14 | B cell receptor signaling pathway (GO:0050853) | 4.07295240 |
| 15 | positive regulation of interferon-alpha production (GO:0032727) | 4.02485738 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 3.83212172 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.82378925 |
| 18 | regulation of interferon-alpha production (GO:0032647) | 3.82282575 |
| 19 | regulation of B cell differentiation (GO:0045577) | 3.78633604 |
| 20 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.77871255 |
| 21 | cellular response to zinc ion (GO:0071294) | 3.61168753 |
| 22 | neutrophil activation (GO:0042119) | 3.54127333 |
| 23 | NIK/NF-kappaB signaling (GO:0038061) | 3.53136613 |
| 24 | response to muramyl dipeptide (GO:0032495) | 3.50410317 |
| 25 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.50227449 |
| 26 | regulation of gamma-delta T cell activation (GO:0046643) | 3.49614400 |
| 27 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.49006343 |
| 28 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.49006343 |
| 29 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.42689176 |
| 30 | germinal center formation (GO:0002467) | 3.40742713 |
| 31 | B cell mediated immunity (GO:0019724) | 3.36610570 |
| 32 | response to peptidoglycan (GO:0032494) | 3.36152405 |
| 33 | granulocyte activation (GO:0036230) | 3.36076213 |
| 34 | negative regulation of granulocyte differentiation (GO:0030853) | 3.35119836 |
| 35 | detection of bacterium (GO:0016045) | 3.24943871 |
| 36 | negative thymic T cell selection (GO:0045060) | 3.22283716 |
| 37 | defense response to protozoan (GO:0042832) | 3.19019473 |
| 38 | thymic T cell selection (GO:0045061) | 3.17757891 |
| 39 | positive regulation of interferon-beta production (GO:0032728) | 3.14969449 |
| 40 | mature B cell differentiation (GO:0002335) | 3.14634859 |
| 41 | detection of other organism (GO:0098543) | 3.12134924 |
| 42 | response to type I interferon (GO:0034340) | 3.11948563 |
| 43 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.10931992 |
| 44 | cellular response to type I interferon (GO:0071357) | 3.07155323 |
| 45 | type I interferon signaling pathway (GO:0060337) | 3.07155323 |
| 46 | respiratory burst (GO:0045730) | 3.05127045 |
| 47 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.03242202 |
| 48 | positive regulation of antigen processing and presentation (GO:0002579) | 3.01764886 |
| 49 | negative T cell selection (GO:0043383) | 3.00853663 |
| 50 | negative regulation of B cell proliferation (GO:0030889) | 2.99583139 |
| 51 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.98262301 |
| 52 | negative regulation of phagocytosis (GO:0050765) | 2.97605346 |
| 53 | myeloid cell activation involved in immune response (GO:0002275) | 2.97300296 |
| 54 | positive thymic T cell selection (GO:0045059) | 2.97257069 |
| 55 | pinocytosis (GO:0006907) | 2.97151020 |
| 56 | response to host immune response (GO:0052572) | 2.95858951 |
| 57 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.95858951 |
| 58 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.93550621 |
| 59 | mannose metabolic process (GO:0006013) | 2.91940628 |
| 60 | B cell homeostasis (GO:0001782) | 2.91055644 |
| 61 | T cell lineage commitment (GO:0002360) | 2.90987434 |
| 62 | natural killer cell mediated immunity (GO:0002228) | 2.90790114 |
| 63 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.90790114 |
| 64 | positive regulation of humoral immune response (GO:0002922) | 2.90150716 |
| 65 | I-kappaB phosphorylation (GO:0007252) | 2.89433011 |
| 66 | T cell selection (GO:0045058) | 2.86778119 |
| 67 | myeloid dendritic cell activation (GO:0001773) | 2.86492257 |
| 68 | response to protozoan (GO:0001562) | 2.84409681 |
| 69 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.84275741 |
| 70 | negative regulation of interleukin-12 production (GO:0032695) | 2.82993034 |
| 71 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.81723413 |
| 72 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.80770627 |
| 73 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.80631563 |
| 74 | response to host (GO:0075136) | 2.80631563 |
| 75 | response to host defenses (GO:0052200) | 2.80631563 |
| 76 | T cell costimulation (GO:0031295) | 2.80391313 |
| 77 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.78689930 |
| 78 | neutrophil mediated immunity (GO:0002446) | 2.78149862 |
| 79 | lymphocyte costimulation (GO:0031294) | 2.77802633 |
| 80 | leukocyte aggregation (GO:0070486) | 2.76228431 |
| 81 | detection of external biotic stimulus (GO:0098581) | 2.71829011 |
| 82 | B cell proliferation (GO:0042100) | 2.71432451 |
| 83 | regulation of mast cell degranulation (GO:0043304) | 2.71277308 |
| 84 | positive T cell selection (GO:0043368) | 2.71139732 |
| 85 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.68997699 |
| 86 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.67820655 |
| 87 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.65821910 |
| 88 | negative regulation of cell killing (GO:0031342) | 2.65821910 |
| 89 | mature B cell differentiation involved in immune response (GO:0002313) | 2.65631133 |
| 90 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.65375718 |
| 91 | regulation of histone H3-K27 methylation (GO:0061085) | 2.63298511 |
| 92 | positive regulation of isotype switching (GO:0045830) | 2.62744445 |
| 93 | myeloid dendritic cell differentiation (GO:0043011) | 2.62249436 |
| 94 | regulation of antigen processing and presentation (GO:0002577) | 2.61117512 |
| 95 | regulation of B cell apoptotic process (GO:0002902) | 2.61024646 |
| 96 | histone H3-K36 demethylation (GO:0070544) | 2.60805942 |
| 97 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.58249648 |
| 98 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.56158357 |
| 99 | regulation of B cell proliferation (GO:0030888) | 2.55997574 |
| 100 | positive regulation of B cell proliferation (GO:0030890) | 2.55242113 |
| 101 | T cell migration (GO:0072678) | 2.55042956 |
| 102 | tolerance induction (GO:0002507) | 2.54991418 |
| 103 | macrophage activation (GO:0042116) | 2.54972979 |
| 104 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.54196058 |
| 105 | cellular response to interferon-beta (GO:0035458) | 2.53275299 |
| 106 | positive regulation of B cell activation (GO:0050871) | 2.52853081 |
| 107 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.52697694 |
| 108 | regulation of interferon-beta production (GO:0032648) | 2.52433585 |
| 109 | regulation of mast cell activation (GO:0033003) | 2.51728897 |
| 110 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.51229543 |
| 111 | cellular extravasation (GO:0045123) | 2.50851737 |
| 112 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.50600182 |
| 113 | lymphocyte homeostasis (GO:0002260) | 2.49798995 |
| 114 | cellular response to virus (GO:0098586) | 2.49180022 |
| 115 | leukocyte cell-cell adhesion (GO:0007159) | 2.48592371 |
| 116 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.48565784 |
| 117 | microglial cell activation (GO:0001774) | 2.48148589 |
| 118 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.46830322 |
| 119 | myeloid leukocyte activation (GO:0002274) | 2.46689213 |
| 120 | detection of molecule of bacterial origin (GO:0032490) | 2.46271979 |
| 121 | positive regulation of myotube differentiation (GO:0010831) | 2.45925391 |
| 122 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.42585643 |
| 123 | positive regulation of B cell mediated immunity (GO:0002714) | 2.42141942 |
| 124 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.42141942 |
| 125 | regulation of interleukin-12 production (GO:0032655) | 2.41814148 |
| 126 | positive regulation of interleukin-12 production (GO:0032735) | 2.40440278 |
| 127 | dendritic cell differentiation (GO:0097028) | 2.40130702 |
| 128 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.39496784 |
| 129 | regulation of integrin activation (GO:0033623) | 2.39149509 |
| 130 | response to interleukin-15 (GO:0070672) | 2.37620218 |
| 131 | T-helper 1 type immune response (GO:0042088) | 2.37202621 |
| 132 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.36981905 |
| 133 | positive regulation of type 2 immune response (GO:0002830) | 2.36551628 |
| 134 | cellular response to interferon-gamma (GO:0071346) | 2.35865673 |
| 135 | detection of biotic stimulus (GO:0009595) | 2.34529573 |
| 136 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.34303308 |
| 137 | activation of JUN kinase activity (GO:0007257) | 2.33327062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.57907359 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.93612000 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.60420706 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.79483554 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.71254258 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.37311696 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.35856516 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.29345773 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.23692875 |
| 10 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.22507682 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.10186845 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 2.90537966 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.89256728 |
| 14 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.87124604 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.86757918 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.82319731 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.74865582 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.67390433 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.67293086 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.41000810 |
| 21 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.34181083 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.28507415 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.26339409 |
| 24 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.16113892 |
| 25 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.14860256 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 2.13401815 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 2.09767572 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.05238198 |
| 29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.04011345 |
| 30 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.02947671 |
| 31 | MYB_26560356_Chip-Seq_TH1_Human | 2.01251372 |
| 32 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.99603736 |
| 33 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.99442944 |
| 34 | SPI1_23127762_ChIP-Seq_K562_Human | 1.98506470 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.94204894 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.92469100 |
| 37 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.90769658 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.88849607 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.87271683 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79425285 |
| 41 | UTX_26944678_Chip-Seq_JUKART_Human | 1.78753414 |
| 42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.54532352 |
| 43 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.53622428 |
| 44 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.52575583 |
| 45 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.52015567 |
| 46 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.49722687 |
| 47 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.45926371 |
| 48 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45184762 |
| 49 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44069517 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43751180 |
| 51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.43517150 |
| 52 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.41663687 |
| 53 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.40524315 |
| 54 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.39331658 |
| 55 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36540799 |
| 56 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34757948 |
| 57 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.33794465 |
| 58 | MAF_26560356_Chip-Seq_TH2_Human | 1.30745147 |
| 59 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.30234889 |
| 60 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29922243 |
| 61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27815560 |
| 62 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.25963366 |
| 63 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22152010 |
| 64 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.21753859 |
| 65 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.20634299 |
| 66 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.19136814 |
| 67 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.17522601 |
| 68 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.17380232 |
| 69 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.17285365 |
| 70 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16492745 |
| 71 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14582013 |
| 72 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.14441251 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14305428 |
| 74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09537908 |
| 75 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.07795681 |
| 76 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.07586536 |
| 77 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06271410 |
| 78 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.05591967 |
| 79 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05146204 |
| 80 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.04410156 |
| 81 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02697821 |
| 82 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.00481007 |
| 83 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.00165154 |
| 84 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.96648415 |
| 85 | KDM2B_26808549_Chip-Seq_K562_Human | 0.96387600 |
| 86 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95445382 |
| 87 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.95292108 |
| 88 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95259911 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.93985577 |
| 90 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.93663605 |
| 91 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92363997 |
| 92 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91914115 |
| 93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91751005 |
| 94 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91572279 |
| 95 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91130156 |
| 96 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.90547472 |
| 97 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89638803 |
| 98 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.87762688 |
| 99 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87507322 |
| 100 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87329665 |
| 101 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86867233 |
| 102 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86470335 |
| 103 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.86294668 |
| 104 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.86128731 |
| 105 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85644341 |
| 106 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.85388518 |
| 107 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.85056338 |
| 108 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84903520 |
| 109 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84082111 |
| 110 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.83831789 |
| 111 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.83695149 |
| 112 | GATA3_26560356_Chip-Seq_TH2_Human | 0.83562788 |
| 113 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.82673919 |
| 114 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79317632 |
| 115 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71377323 |
| 116 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70902409 |
| 117 | GATA2_19941826_ChIP-Seq_K562_Human | 0.70293826 |
| 118 | GATA1_19941826_ChIP-Seq_K562_Human | 0.69794172 |
| 119 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.69081552 |
| 120 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.68550115 |
| 121 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.67637360 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.27811458 |
| 2 | MP0000685_abnormal_immune_system | 3.08463530 |
| 3 | MP0001800_abnormal_humoral_immune | 2.99490239 |
| 4 | MP0003303_peritoneal_inflammation | 2.95503487 |
| 5 | MP0001790_abnormal_immune_system | 2.95309167 |
| 6 | MP0005387_immune_system_phenotype | 2.95309167 |
| 7 | MP0000569_abnormal_digit_pigmentation | 2.79971434 |
| 8 | MP0003436_decreased_susceptibility_to | 2.75665820 |
| 9 | MP0002452_abnormal_antigen_presenting | 2.73618582 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.59808487 |
| 11 | MP0002396_abnormal_hematopoietic_system | 2.51755312 |
| 12 | MP0005671_abnormal_response_to | 2.50215321 |
| 13 | MP0002419_abnormal_innate_immunity | 2.46326373 |
| 14 | MP0002723_abnormal_immune_serum | 2.43917693 |
| 15 | MP0005025_abnormal_response_to | 2.35488416 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.33343726 |
| 17 | MP0001819_abnormal_immune_cell | 2.32965548 |
| 18 | MP0009278_abnormal_bone_marrow | 2.29787110 |
| 19 | MP0009785_altered_susceptibility_to | 2.23916179 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.18352748 |
| 21 | MP0002398_abnormal_bone_marrow | 2.12360190 |
| 22 | MP0003705_abnormal_hypodermis_morpholog | 2.09630937 |
| 23 | MP0008438_abnormal_cutaneous_collagen | 2.04156106 |
| 24 | MP0002166_altered_tumor_susceptibility | 2.03758771 |
| 25 | MP0005174_abnormal_tail_pigmentation | 2.01129600 |
| 26 | MP0005464_abnormal_platelet_physiology | 1.97820686 |
| 27 | MP0000716_abnormal_immune_system | 1.93956132 |
| 28 | MP0005058_abnormal_lysosome_morphology | 1.93780665 |
| 29 | MP0002405_respiratory_system_inflammati | 1.90148071 |
| 30 | MP0000689_abnormal_spleen_morphology | 1.87805378 |
| 31 | MP0008057_abnormal_DNA_replication | 1.87034677 |
| 32 | MP0006082_CNS_inflammation | 1.83568512 |
| 33 | MP0002138_abnormal_hepatobiliary_system | 1.82544029 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.82067864 |
| 35 | MP0003172_abnormal_lysosome_physiology | 1.80607180 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.79255219 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.79255219 |
| 38 | MP0001853_heart_inflammation | 1.76322413 |
| 39 | MP0004510_myositis | 1.75166588 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.74803137 |
| 41 | MP0004808_abnormal_hematopoietic_stem | 1.73177216 |
| 42 | MP0005451_abnormal_body_composition | 1.72154494 |
| 43 | MP0003279_aneurysm | 1.69127254 |
| 44 | MP0002722_abnormal_immune_system | 1.68123200 |
| 45 | MP0002429_abnormal_blood_cell | 1.66482011 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.66027374 |
| 47 | MP0001873_stomach_inflammation | 1.64161756 |
| 48 | MP0002006_tumorigenesis | 1.62870714 |
| 49 | MP0003763_abnormal_thymus_physiology | 1.61394031 |
| 50 | MP0010352_gastrointestinal_tract_polyps | 1.61356137 |
| 51 | MP0004947_skin_inflammation | 1.59505745 |
| 52 | MP0000465_gastrointestinal_hemorrhage | 1.55467996 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.53472717 |
| 54 | MP0001348_abnormal_lacrimal_gland | 1.46111654 |
| 55 | MP0009333_abnormal_splenocyte_physiolog | 1.45358824 |
| 56 | MP0010307_abnormal_tumor_latency | 1.42356566 |
| 57 | MP0003724_increased_susceptibility_to | 1.42159332 |
| 58 | MP0003191_abnormal_cellular_cholesterol | 1.41691349 |
| 59 | MP0000490_abnormal_crypts_of | 1.39172932 |
| 60 | MP0003950_abnormal_plasma_membrane | 1.35507182 |
| 61 | MP0001533_abnormal_skeleton_physiology | 1.33914822 |
| 62 | MP0005076_abnormal_cell_differentiation | 1.33672821 |
| 63 | MP0000703_abnormal_thymus_morphology | 1.33577194 |
| 64 | MP0002877_abnormal_melanocyte_morpholog | 1.31460188 |
| 65 | MP0003448_altered_tumor_morphology | 1.28235291 |
| 66 | MP0003828_pulmonary_edema | 1.28108659 |
| 67 | MP0003566_abnormal_cell_adhesion | 1.26489519 |
| 68 | MP0000858_altered_metastatic_potential | 1.25425908 |
| 69 | MP0005623_abnormal_meninges_morphology | 1.22855868 |
| 70 | MP0000015_abnormal_ear_pigmentation | 1.21748589 |
| 71 | MP0005310_abnormal_salivary_gland | 1.17383058 |
| 72 | MP0008469_abnormal_protein_level | 1.15402982 |
| 73 | MP0002933_joint_inflammation | 1.10513341 |
| 74 | MP0003866_abnormal_defecation | 1.06592470 |
| 75 | MP0003077_abnormal_cell_cycle | 1.04648017 |
| 76 | MP0010368_abnormal_lymphatic_system | 1.03727426 |
| 77 | MP0000343_altered_response_to | 1.03208152 |
| 78 | MP0008260_abnormal_autophagy | 1.00061827 |
| 79 | MP0005075_abnormal_melanosome_morpholog | 0.99691322 |
| 80 | MP0005257_abnormal_intraocular_pressure | 0.99532774 |
| 81 | MP0002998_abnormal_bone_remodeling | 0.99199181 |
| 82 | MP0000003_abnormal_adipose_tissue | 0.98974358 |
| 83 | MP0005360_urolithiasis | 0.96904911 |
| 84 | MP0002019_abnormal_tumor_incidence | 0.96402185 |
| 85 | MP0003111_abnormal_nucleus_morphology | 0.95635872 |
| 86 | MP0003091_abnormal_cell_migration | 0.93725164 |
| 87 | MP0000371_diluted_coat_color | 0.92808951 |
| 88 | MP0010094_abnormal_chromosome_stability | 0.92571580 |
| 89 | MP0009115_abnormal_fat_cell | 0.91327673 |
| 90 | MP0003693_abnormal_embryo_hatching | 0.90834513 |
| 91 | MP0004185_abnormal_adipocyte_glucose | 0.87148050 |
| 92 | MP0000767_abnormal_smooth_muscle | 0.86934480 |
| 93 | MP0009384_cardiac_valve_regurgitation | 0.85638288 |
| 94 | MP0008058_abnormal_DNA_repair | 0.84782886 |
| 95 | MP0005023_abnormal_wound_healing | 0.84754193 |
| 96 | MP0001663_abnormal_digestive_system | 0.83911322 |
| 97 | MP0003045_fibrosis | 0.81419041 |
| 98 | MP0001915_intracranial_hemorrhage | 0.80814804 |
| 99 | MP0005375_adipose_tissue_phenotype | 0.79752901 |
| 100 | MP0009764_decreased_sensitivity_to | 0.79642536 |
| 101 | MP0003453_abnormal_keratinocyte_physiol | 0.79351278 |
| 102 | MP0000249_abnormal_blood_vessel | 0.78963709 |
| 103 | MP0002254_reproductive_system_inflammat | 0.78824275 |
| 104 | MP0004858_abnormal_nervous_system | 0.77433640 |
| 105 | MP0008007_abnormal_cellular_replicative | 0.77323814 |
| 106 | MP0002009_preneoplasia | 0.76940526 |
| 107 | MP0005670_abnormal_white_adipose | 0.76800823 |
| 108 | MP0001851_eye_inflammation | 0.76461031 |
| 109 | MP0002928_abnormal_bile_duct | 0.73988143 |
| 110 | MP0006054_spinal_hemorrhage | 0.73227222 |
| 111 | MP0005390_skeleton_phenotype | 0.73164663 |
| 112 | MP0005164_abnormal_response_to | 0.71468049 |
| 113 | MP0009840_abnormal_foam_cell | 0.70973155 |
| 114 | MP0000313_abnormal_cell_death | 0.70120923 |
| 115 | MP0005621_abnormal_cell_physiology | 0.69843145 |
| 116 | MP0002095_abnormal_skin_pigmentation | 0.69750426 |
| 117 | MP0001879_abnormal_lymphatic_vessel | 0.65171109 |
| 118 | MP0005666_abnormal_adipose_tissue | 0.64069826 |
| 119 | MP0009763_increased_sensitivity_to | 0.63661236 |
| 120 | MP0004883_abnormal_blood_vessel | 0.63407159 |
| 121 | MP0005166_decreased_susceptibility_to | 0.62481397 |
| 122 | MP0005503_abnormal_tendon_morphology | 0.62365557 |
| 123 | MP0000350_abnormal_cell_proliferation | 0.61981600 |
| 124 | MP0004272_abnormal_basement_membrane | 0.60859257 |
| 125 | MP0002136_abnormal_kidney_physiology | 0.60302822 |
| 126 | MP0003795_abnormal_bone_structure | 0.56102018 |
| 127 | MP0004264_abnormal_extraembryonic_tissu | 0.55529113 |
| 128 | MP0001958_emphysema | 0.54536358 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.35888115 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.88738449 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.30751713 |
| 4 | Recurrent viral infections (HP:0004429) | 4.10608640 |
| 5 | Cellulitis (HP:0100658) | 3.84114882 |
| 6 | Recurrent fungal infections (HP:0002841) | 3.82217032 |
| 7 | Agammaglobulinemia (HP:0004432) | 3.68818400 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.63539868 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 3.58836527 |
| 10 | Colitis (HP:0002583) | 3.55684646 |
| 11 | Autoimmune thrombocytopenia (HP:0001973) | 3.46346685 |
| 12 | Abnormality of the fingertips (HP:0001211) | 3.40887907 |
| 13 | IgM deficiency (HP:0002850) | 3.39493269 |
| 14 | Myositis (HP:0100614) | 3.32113782 |
| 15 | Protrusio acetabuli (HP:0003179) | 3.28347915 |
| 16 | Meningitis (HP:0001287) | 3.25340686 |
| 17 | Recurrent skin infections (HP:0001581) | 3.25320038 |
| 18 | Inflammation of the large intestine (HP:0002037) | 3.22307206 |
| 19 | Vasculitis (HP:0002633) | 3.16381076 |
| 20 | Gastrointestinal inflammation (HP:0004386) | 3.11020667 |
| 21 | Abnormality of macrophages (HP:0004311) | 3.03339581 |
| 22 | Gastrointestinal stroma tumor (HP:0100723) | 2.99375612 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 2.96132306 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.96132306 |
| 25 | Osteomyelitis (HP:0002754) | 2.88733367 |
| 26 | Periodontitis (HP:0000704) | 2.84024229 |
| 27 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.83912237 |
| 28 | Gingivitis (HP:0000230) | 2.80537570 |
| 29 | Recurrent bronchitis (HP:0002837) | 2.80136761 |
| 30 | Recurrent pneumonia (HP:0006532) | 2.70760600 |
| 31 | Obstructive lung disease (HP:0006536) | 2.70656533 |
| 32 | Chronic obstructive pulmonary disease (HP:0006510) | 2.70656533 |
| 33 | Orchitis (HP:0100796) | 2.70224494 |
| 34 | Panhypogammaglobulinemia (HP:0003139) | 2.70084788 |
| 35 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.66971635 |
| 36 | Aortic aneurysm (HP:0004942) | 2.66369779 |
| 37 | Hematochezia (HP:0002573) | 2.65631412 |
| 38 | Chronic otitis media (HP:0000389) | 2.65492634 |
| 39 | Abnormality of the peritoneum (HP:0002585) | 2.62876534 |
| 40 | Recurrent lower respiratory tract infections (HP:0002783) | 2.54590552 |
| 41 | Optic neuritis (HP:0100653) | 2.53462858 |
| 42 | Retrobulbar optic neuritis (HP:0100654) | 2.53462858 |
| 43 | Lymphopenia (HP:0001888) | 2.51767740 |
| 44 | Thyroiditis (HP:0100646) | 2.51356315 |
| 45 | Spontaneous hematomas (HP:0007420) | 2.51150951 |
| 46 | Pustule (HP:0200039) | 2.51056440 |
| 47 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.42206347 |
| 48 | Peritonitis (HP:0002586) | 2.40455559 |
| 49 | Emphysema (HP:0002097) | 2.40405323 |
| 50 | Vacuolated lymphocytes (HP:0001922) | 2.38212445 |
| 51 | Fatigue (HP:0012378) | 2.37314974 |
| 52 | Interstitial pulmonary disease (HP:0006530) | 2.36754347 |
| 53 | Prolonged bleeding time (HP:0003010) | 2.36390367 |
| 54 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.35111172 |
| 55 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.35111172 |
| 56 | Abnormality of glycolipid metabolism (HP:0010969) | 2.35111172 |
| 57 | Gastrointestinal infarctions (HP:0005244) | 2.33056565 |
| 58 | B lymphocytopenia (HP:0010976) | 2.28788419 |
| 59 | Abnormality of B cell number (HP:0010975) | 2.28788419 |
| 60 | Eosinophilia (HP:0001880) | 2.27157460 |
| 61 | Leukocytosis (HP:0001974) | 2.27069233 |
| 62 | Increased IgE level (HP:0003212) | 2.26978531 |
| 63 | Increased cerebral lipofuscin (HP:0011813) | 2.24665757 |
| 64 | Premature rupture of membranes (HP:0001788) | 2.23695679 |
| 65 | IgA deficiency (HP:0002720) | 2.23364965 |
| 66 | Leukopenia (HP:0001882) | 2.21706017 |
| 67 | Systemic lupus erythematosus (HP:0002725) | 2.21290355 |
| 68 | Pulmonary infiltrates (HP:0002113) | 2.21029143 |
| 69 | Restrictive lung disease (HP:0002091) | 2.20915143 |
| 70 | Thrombocytosis (HP:0001894) | 2.19223813 |
| 71 | Spinal cord lesions (HP:0100561) | 2.19191809 |
| 72 | Syringomyelia (HP:0003396) | 2.19191809 |
| 73 | Stomatitis (HP:0010280) | 2.18857194 |
| 74 | Petechiae (HP:0000967) | 2.18159440 |
| 75 | Abnormality of T cell physiology (HP:0011840) | 2.16527127 |
| 76 | Verrucae (HP:0200043) | 2.14446375 |
| 77 | Papilloma (HP:0012740) | 2.14446375 |
| 78 | Agnosia (HP:0010524) | 2.11347580 |
| 79 | Granulocytopenia (HP:0001913) | 2.09474763 |
| 80 | Sepsis (HP:0100806) | 2.09106364 |
| 81 | Recurrent sinusitis (HP:0011108) | 2.07460944 |
| 82 | Basal ganglia calcification (HP:0002135) | 2.07000581 |
| 83 | Aortic dissection (HP:0002647) | 2.06134579 |
| 84 | Absent frontal sinuses (HP:0002688) | 2.05796512 |
| 85 | Viral hepatitis (HP:0006562) | 2.04492794 |
| 86 | Chest pain (HP:0100749) | 2.04439022 |
| 87 | Abnormality of T cells (HP:0002843) | 2.02811835 |
| 88 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.02458797 |
| 89 | Lymphoma (HP:0002665) | 2.00998638 |
| 90 | Cheilitis (HP:0100825) | 1.99324610 |
| 91 | Disproportionate tall stature (HP:0001519) | 1.98588830 |
| 92 | Thoracic kyphosis (HP:0002942) | 1.97937018 |
| 93 | Dilatation of the ascending aorta (HP:0005111) | 1.97170759 |
| 94 | Arterial thrombosis (HP:0004420) | 1.96572255 |
| 95 | Skin ulcer (HP:0200042) | 1.96526560 |
| 96 | Dysostosis multiplex (HP:0000943) | 1.94543387 |
| 97 | Gingival bleeding (HP:0000225) | 1.94489204 |
| 98 | Cerebral aneurysm (HP:0004944) | 1.93474408 |
| 99 | Urticaria (HP:0001025) | 1.92742624 |
| 100 | Hypertensive crisis (HP:0100735) | 1.92387037 |
| 101 | Hemoptysis (HP:0002105) | 1.92248579 |
| 102 | Hypoplasia of the thymus (HP:0000778) | 1.90032028 |
| 103 | Spondylolisthesis (HP:0003302) | 1.89288767 |
| 104 | Chromsome breakage (HP:0040012) | 1.89096652 |
| 105 | Myocardial infarction (HP:0001658) | 1.88314831 |
| 106 | Aneurysm (HP:0002617) | 1.88122383 |
| 107 | Abnormality of the thoracic spine (HP:0100711) | 1.87824149 |
| 108 | Persistence of primary teeth (HP:0006335) | 1.87630785 |
| 109 | Encephalitis (HP:0002383) | 1.87489268 |
| 110 | Urethral obstruction (HP:0000796) | 1.86759663 |
| 111 | Acrocyanosis (HP:0001063) | 1.86415190 |
| 112 | Flat acetabular roof (HP:0003180) | 1.86032590 |
| 113 | Thoracolumbar scoliosis (HP:0002944) | 1.86020399 |
| 114 | Abnormality of T cell number (HP:0011839) | 1.85857158 |
| 115 | Abnormality of eosinophils (HP:0001879) | 1.85136491 |
| 116 | Long eyelashes (HP:0000527) | 1.84867496 |
| 117 | Disinhibition (HP:0000734) | 1.84705867 |
| 118 | Chronic diarrhea (HP:0002028) | 1.84207608 |
| 119 | Axonal loss (HP:0003447) | 1.82868978 |
| 120 | Prostate neoplasm (HP:0100787) | 1.82113553 |
| 121 | Epistaxis (HP:0000421) | 1.81765335 |
| 122 | Hemorrhage of the eye (HP:0011885) | 1.81215189 |
| 123 | T lymphocytopenia (HP:0005403) | 1.81206175 |
| 124 | Mitral valve prolapse (HP:0001634) | 1.80064717 |
| 125 | Premature loss of primary teeth (HP:0006323) | 1.79410659 |
| 126 | Nonimmune hydrops fetalis (HP:0001790) | 1.79260643 |
| 127 | Flexion contracture of toe (HP:0005830) | 1.78892508 |
| 128 | Joint contractures involving the joints of the feet (HP:0100492) | 1.78892508 |
| 129 | Long palpebral fissure (HP:0000637) | 1.78590149 |
| 130 | Vertebral compression fractures (HP:0002953) | 1.78282818 |
| 131 | IgG deficiency (HP:0004315) | 1.78017179 |
| 132 | Conjunctival telangiectasia (HP:0000524) | 1.77531630 |
| 133 | Asymmetric septal hypertrophy (HP:0001670) | 1.76020024 |
| 134 | Abnormality of the pleura (HP:0002103) | 1.74832217 |
| 135 | Malnutrition (HP:0004395) | 1.73391768 |
| 136 | Blue sclerae (HP:0000592) | 1.73130784 |
| 137 | Skin rash (HP:0000988) | 1.73045508 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.26728250 |
| 2 | CDK12 | 2.88808774 |
| 3 | PRPF4B | 2.77169282 |
| 4 | TYK2 | 2.70036269 |
| 5 | ERN1 | 2.61861732 |
| 6 | BLK | 2.59542322 |
| 7 | RIPK4 | 2.57675565 |
| 8 | MAP3K14 | 2.54598791 |
| 9 | KIT | 2.53664021 |
| 10 | IRAK4 | 2.49784380 |
| 11 | MAP3K10 | 2.42098077 |
| 12 | SMG1 | 2.37996933 |
| 13 | CSF1R | 2.37251396 |
| 14 | TRIB3 | 2.28898303 |
| 15 | IRAK3 | 2.25916244 |
| 16 | TBK1 | 2.21556858 |
| 17 | TGFBR2 | 2.08174839 |
| 18 | JAK3 | 2.00729955 |
| 19 | IKBKE | 1.97900418 |
| 20 | IKBKB | 1.93470736 |
| 21 | TAOK3 | 1.83957923 |
| 22 | STK10 | 1.83423363 |
| 23 | BTK | 1.74999713 |
| 24 | CDC42BPA | 1.60951872 |
| 25 | JAK1 | 1.55802966 |
| 26 | SYK | 1.51851401 |
| 27 | ZAP70 | 1.51127061 |
| 28 | EEF2K | 1.51004516 |
| 29 | MAP3K13 | 1.49473441 |
| 30 | GRK6 | 1.48346451 |
| 31 | TEC | 1.41309082 |
| 32 | RPS6KA4 | 1.40157950 |
| 33 | CSK | 1.37377949 |
| 34 | HCK | 1.36584782 |
| 35 | TXK | 1.34573689 |
| 36 | CHUK | 1.33494349 |
| 37 | PIM1 | 1.33076336 |
| 38 | MATK | 1.31501423 |
| 39 | MAP2K3 | 1.29348382 |
| 40 | BRD4 | 1.28245932 |
| 41 | SIK1 | 1.27628721 |
| 42 | CAMK1D | 1.20160934 |
| 43 | SIK2 | 1.17793281 |
| 44 | LYN | 1.14861226 |
| 45 | PIM2 | 1.10923944 |
| 46 | CLK1 | 1.10187586 |
| 47 | LCK | 1.09696327 |
| 48 | TAOK2 | 1.08274877 |
| 49 | MAP3K7 | 1.04785001 |
| 50 | MARK3 | 1.04679921 |
| 51 | TRPM7 | 1.02344986 |
| 52 | CDK4 | 0.99953928 |
| 53 | PDGFRA | 0.96832661 |
| 54 | CAMK1G | 0.96554329 |
| 55 | CDK6 | 0.90833786 |
| 56 | FGFR3 | 0.90811831 |
| 57 | EPHB1 | 0.88030970 |
| 58 | FLT3 | 0.87533468 |
| 59 | STK4 | 0.87305212 |
| 60 | NEK2 | 0.87216290 |
| 61 | DDR2 | 0.86578198 |
| 62 | SIK3 | 0.84918872 |
| 63 | LRRK2 | 0.84255069 |
| 64 | ITK | 0.84068255 |
| 65 | FES | 0.80177062 |
| 66 | TESK2 | 0.78853696 |
| 67 | PDK1 | 0.78453213 |
| 68 | MAP3K11 | 0.76868806 |
| 69 | PTK6 | 0.75625173 |
| 70 | PDPK1 | 0.74898921 |
| 71 | MAP2K2 | 0.70254135 |
| 72 | MARK2 | 0.70209201 |
| 73 | KSR2 | 0.69479312 |
| 74 | ATR | 0.67525890 |
| 75 | YES1 | 0.67355431 |
| 76 | PIK3CG | 0.63813879 |
| 77 | CDK7 | 0.63053822 |
| 78 | TNK2 | 0.60682532 |
| 79 | MAP3K1 | 0.60590072 |
| 80 | MAP3K8 | 0.59160389 |
| 81 | CDK9 | 0.57885433 |
| 82 | JAK2 | 0.57787264 |
| 83 | NEK9 | 0.57696484 |
| 84 | ABL1 | 0.56697711 |
| 85 | MAPK12 | 0.55769881 |
| 86 | FGFR4 | 0.54851717 |
| 87 | MAPKAPK2 | 0.54231243 |
| 88 | STK3 | 0.52388335 |
| 89 | HIPK2 | 0.51925891 |
| 90 | MAPK7 | 0.51652722 |
| 91 | MAPKAPK3 | 0.51380105 |
| 92 | KDR | 0.48478874 |
| 93 | BMX | 0.48036266 |
| 94 | MAP3K3 | 0.48011183 |
| 95 | RPS6KA2 | 0.47568106 |
| 96 | PAK4 | 0.47351670 |
| 97 | ICK | 0.47213796 |
| 98 | MST4 | 0.47122909 |
| 99 | RPS6KA6 | 0.46592772 |
| 100 | RIPK1 | 0.46573077 |
| 101 | MOS | 0.46114344 |
| 102 | EGFR | 0.45137268 |
| 103 | FGR | 0.44861570 |
| 104 | TTN | 0.44096377 |
| 105 | PAK2 | 0.43960772 |
| 106 | MAP3K5 | 0.41442252 |
| 107 | PRKCQ | 0.41127084 |
| 108 | MTOR | 0.40513187 |
| 109 | BMPR2 | 0.39097984 |
| 110 | NLK | 0.38921280 |
| 111 | RPS6KL1 | 0.38112872 |
| 112 | RPS6KC1 | 0.38112872 |
| 113 | DYRK1B | 0.37592738 |
| 114 | MAPK11 | 0.37589842 |
| 115 | RPS6KB2 | 0.36689403 |
| 116 | PRKD2 | 0.34586387 |
| 117 | DYRK3 | 0.34259347 |
| 118 | TGFBR1 | 0.34236899 |
| 119 | NUAK1 | 0.33854795 |
| 120 | PKN2 | 0.33264892 |
| 121 | MAPK15 | 0.31640433 |
| 122 | PRKCD | 0.29411894 |
| 123 | GRK1 | 0.28528856 |
| 124 | SCYL2 | 0.27881020 |
| 125 | MAPK3 | 0.27859358 |
| 126 | MELK | 0.25228043 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.92018925 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.89376302 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.57594476 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.55896171 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.48862947 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.29432075 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.08289717 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.99756180 |
| 9 | Measles_Homo sapiens_hsa05162 | 1.97452147 |
| 10 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.93470638 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.87733211 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.84995877 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.79466714 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.76945219 |
| 15 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.75975602 |
| 16 | Influenza A_Homo sapiens_hsa05164 | 1.70206551 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.67445423 |
| 18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.67182261 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.66362807 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.62269616 |
| 21 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.60721307 |
| 22 | Pertussis_Homo sapiens_hsa05133 | 1.57256135 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.57064379 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.52752562 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.49164650 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.48875160 |
| 27 | Apoptosis_Homo sapiens_hsa04210 | 1.45718430 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.45176342 |
| 29 | Legionellosis_Homo sapiens_hsa05134 | 1.45135247 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.43954684 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.37143605 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.37058912 |
| 33 | Base excision repair_Homo sapiens_hsa03410 | 1.35906874 |
| 34 | Hepatitis B_Homo sapiens_hsa05161 | 1.34438345 |
| 35 | DNA replication_Homo sapiens_hsa03030 | 1.33211256 |
| 36 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.31786610 |
| 37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.31160816 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.29305209 |
| 39 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.25007231 |
| 40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.23099954 |
| 41 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.21655542 |
| 42 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.20722260 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.19971757 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.16108570 |
| 45 | Allograft rejection_Homo sapiens_hsa05330 | 1.15420940 |
| 46 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.14865858 |
| 47 | Lysosome_Homo sapiens_hsa04142 | 1.14146550 |
| 48 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.06610990 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.06314825 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.05386613 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 1.02608875 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 1.02573618 |
| 53 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.02381237 |
| 54 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.99602921 |
| 55 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98547026 |
| 56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.97194478 |
| 57 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.97025969 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.92331843 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.89475114 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.89425482 |
| 61 | Asthma_Homo sapiens_hsa05310 | 0.89115470 |
| 62 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.88420377 |
| 63 | Mismatch repair_Homo sapiens_hsa03430 | 0.86897747 |
| 64 | Bladder cancer_Homo sapiens_hsa05219 | 0.86624192 |
| 65 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84215708 |
| 66 | Homologous recombination_Homo sapiens_hsa03440 | 0.83627738 |
| 67 | HTLV-I infection_Homo sapiens_hsa05166 | 0.83101888 |
| 68 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.82364659 |
| 69 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.78446781 |
| 70 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78359691 |
| 71 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.72857470 |
| 72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69650473 |
| 73 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67548567 |
| 74 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66590565 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63073828 |
| 76 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.61503261 |
| 77 | Lysine degradation_Homo sapiens_hsa00310 | 0.60791646 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.60029793 |
| 79 | Cell cycle_Homo sapiens_hsa04110 | 0.59666953 |
| 80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59578133 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59250014 |
| 82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58765623 |
| 83 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58612874 |
| 84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58017660 |
| 85 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.54982426 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54236505 |
| 87 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53581007 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51740433 |
| 89 | Adherens junction_Homo sapiens_hsa04520 | 0.51656745 |
| 90 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.51423793 |
| 91 | Prostate cancer_Homo sapiens_hsa05215 | 0.51387924 |
| 92 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50556797 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49926782 |
| 94 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49583553 |
| 95 | Spliceosome_Homo sapiens_hsa03040 | 0.49278780 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49190598 |
| 97 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.48951974 |
| 98 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.48594212 |
| 99 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47970781 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47768384 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.47753276 |
| 102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46330734 |
| 103 | Amoebiasis_Homo sapiens_hsa05146 | 0.46181374 |
| 104 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.44505592 |
| 105 | Pathways in cancer_Homo sapiens_hsa05200 | 0.44155310 |
| 106 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42799458 |
| 107 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.39570604 |
| 108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38356667 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38281644 |
| 110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38208376 |
| 111 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.38149398 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.38123365 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37836719 |
| 114 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.37717517 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37401014 |
| 116 | Focal adhesion_Homo sapiens_hsa04510 | 0.36892166 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36781850 |
| 118 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35516947 |
| 119 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35160238 |

